Clinical Trials Directory

Trials / Completed

CompletedNCT01293591

Garlic Intake And Biomarkers Of Cancer Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
USDA Beltsville Human Nutrition Research Center · Federal
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study is being done to study the healthful benefits of eating garlic. Previous studies suggest that garlic may help prevent cancer. The investigators are recruiting healthy volunteers to participate in a study to determine the ways in which eating garlic may reduce cancer risk.

Detailed description

A crossover design will be utilized with each participant completing each treatment phase; participants will be randomly assigned to a sequence of dietary treatments. There will be a 17-day washout period in between diet periods. Participants will consume a garlic-free diet for the first 10 days of each diet period. The dietary treatments will be administered on day 11 of each diet period. Dietary treatments will be incorporated into food as follows: 1) 5 g (0.175 oz.) of garlic mixed with 15 g margarine on top of 270 kcal white bread, served as breakfast, or 2) 15 g margarine on top of 270 kcal white bread, served as breakfast.

Conditions

Interventions

TypeNameDescription
OTHERControlSubjects will consume a garlic-free diet for 10 days. On day 11, subjects will consume 270 kcal white bread with 15 g margarine.
OTHERGarlic treatmentSubjects will consume a garlic-free diet for 10 days. On day 11, subjects will consume 270 kcal white bread with 15 g margarine and 5 g crushed garlic.

Timeline

Start date
2010-07-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2011-02-10
Last updated
2017-06-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01293591. Inclusion in this directory is not an endorsement.